Kamada Ltd (KMDA) stock
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.07−0.09 (-1.10%)
Close on Nov 18, 2026Market cap $465.53MP/E –Yield –
Kamada net income
Net income is the profit left for shareholders after every expense, interest and tax.
Kamada's net income for the twelve months ending Sep 30, 2025 was $20.44M, up 30.1% year over year. For fiscal 2024 it was $14.46M, up 74.6% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $14.46M | +74.6% |
| FY2023 | Dec 31, 2023 | $8.28M | – |
| FY2022 | Dec 31, 2022 | -$2.32M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $5.30M | +37.1% |
| Q2 FY2025 | Jun 30, 2025 | $7.38M | +66.7% |
| Q1 FY2025 | Mar 31, 2025 | $3.96M | +67.6% |
| Q4 FY2024 | Dec 31, 2024 | $3.81M | -24.7% |
| Q3 FY2024 | Sep 30, 2024 | $3.86M | +19.9% |
| Q2 FY2024 | Jun 30, 2024 | $4.43M | +144.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.37M | – |
| Q4 FY2023 | Dec 31, 2023 | $5.06M | – |
| Q3 FY2023 | Sep 30, 2023 | $3.22M | +665809.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.81K | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.32M | – |
| Q3 FY2022 | Sep 30, 2022 | $484 | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.92M | – |
See a number that looks wrong?